Cosmo Bio Co., Ltd. engages in export, import, and sale of bio-research reagents, instruments and software, and clinical diagnostics. Its products include research reagents for immunology, gene engineering, tissue culture, and biochemistry. The company was founded on August 25, 1983 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company